Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
boston top stories
clinical trials
4
×
life sciences
national blog main
boston
cancer
fda
gene editing
investing
national top stories
new york blog main
startups
allergan
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
ascension ventures
avrobio
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer immunotherapy
codiak biosciences
cormorant asset management
crispr
crispr therapeutics
crispr-cas9
cutaneous t-cell lymphoma
cynthia collins
deals
denali therapeutics
detroit blog main
detroit top stories
digital health
drugs
editas medicine
eidos therapeutics
What
clinical
4
×
million
ahead
aiming
allergan
ambien
american
annual
asco
attendees
attention
based
begin
biosciences
biotech
bio’s
blessing
bosley
brings
bubbles
camp’s
cancer
cash
cells
ceo
check
chicago
city
class
closed
codiak
combinations
community’s
company
crispr
cusp
days
depart
digital
drug
Language
unset
Current search:
clinical
×
" boston blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
